The company announced yesterday that it will be acquired by Royal DSM. The company reported net sales of $4.8 million in sports medicine, $4.1 million in spine products and $2.7 million in trauma and craniomaxillofacial products. According to President and CEO Joe Kaufman, the increase in sports medicine sales was due to organic growth, and spine sales increase was driven by the organic growth from Stryker and its acquisition of the Norian business in May 2011.
However, royalty income decreased 6 percent from the same period last year, reaching $6.1 million during the third quarter.
More Articles on Orthopedic Devices:
Symmetry Medical Reports 39% Q1 Net Income Loss
Wright Medical Group Sales Fall 5% After Distributor Transitions
DJO Global Net Sales Jump 11.7%
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
